ProUroCare Medical Inc. (OTCBB: PUMD) (OTCBB: PUMDU) (OTCBB: PUMDW), a provider of proprietary medical imaging products, announced that a 510(k) application for U.S. market clearance of a prostate mechanical imaging system has been filed with the Food & Drug Administration (FDA).

See the original post here:
ProUroCare Medical Announces Filing Of 510(k) For Prostate Imaging System

Related posts:

1. FDA Lags On 510(k) Medical Device ApprovalsAccording to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005...
2. SafeStitch Medical, Inc. Receives FDA Clearance To Market The AMID StaplerTM For Hernia RepairsSafeStitch Medical, Inc. (OTCBB:SFES) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market its AMID StaplerTM in the U.S. with the intended...
3. Boston Scientific Announces FDA Clearance And CE Mark For WallFlex(R) Fully Covered Esophageal StentBoston Scientific Corporation (NYSE: BSX) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered...
4. Nasal-Aire(R) II Petite Receives FDA 510(k) Clearance For Pediatric UseIt is estimated that almost 2 million kids in the United States alone suffer from obstructive sleep apnea (OSA) and may require continuous positive airway pressure (CPAP) therapy. This number...
5. FDA Makes Interim Recommendations To Address Concern Of Excess Radiation Exposure During CT Perfusion ImagingAs part of an ongoing investigation into cases of excess radiation during CT perfusion imaging of the brain, the U.S. Food and Drug Administration provided imaging facilities and practitioners with...
6. Dilon Diagnostics Gamma-Guided Localization System Cleared By FDADilon Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance. GammaLoc(®), pronounced "gamma-loke", is a complementary...
7. United States Olympic Committee Announces D.I.S.C. Sports And Spine Center As An Official Medical Services ProviderThe United States Olympic Committee (USOC) and D.I.S.C. Sports and Spine Center today officially announced a strategic partnership in which D.I.S.C. will become an Official Medical Services Provider through the...
8. DGIMED Receives FDA Clearance On IM Nail SystemDGIMED ORTHO, Inc. announced that the company has received notification of clearance on its 510(k) submission for the Company's proprietary Drill and Intramedullary (IM) Nail system. "This timely notification keeps...
9. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review For Intravenous Acetaminophen By Three MonthsCadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its Priority Review of...
10. Prism And Medical College Of Wisconsin Investigators Receive $1.6 Million NIH Grant To Develop Advanced Medical Imaging ToolsPrism Clinical Imaging, Inc., in collaboration with investigators at The Medical College of Wisconsin in Milwaukee, has received a $1.6 million, three-year grant from the National Institutes of Health (NIH)...
11. Very Common Condition In Women That Often Goes Undiagnosed Now Identifiable By Medical Imaging TechniqueIn women with lower urinary tract symptoms, a medical imaging technique called dynamic MRI allows clinicians to diagnose pelvic organ prolapse - a condition that often goes undiagnosed on static...
12. FDA Announces New Warning On Plavix: Avoid Use With Prilosec/Prilosec OTCPatients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17. New data suggest...
13. Santarus Announces FDA Approval Of Schering-Plough HealthCare Products’ ZEGERID OTCSantarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.'s, New Drug Application (NDA) for ZEGERID...
14. Canon U.S.A. Launches Digital Printing Solution For Healthcare Professionals At RSNA 2009At the 2009 Radiological Society of North America Annual Meeting (RSNA 2009), Canon U.S.A., Inc., a leader in digital advanced imaging technologies (Booth #8339), will showcase the Canon imagePRESS C1+...
15. White House Announces $600 Million For Community Health Centers, Medical RecordsThe White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records. The Associated Press: "The administration plans to give almost $509...